Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2003
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2469944A1 Medicaments comprising n, n'-disubstituted piperazine compounds and their use
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468687A1 Liquid bisphosphonate formulations for bone disorders
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321148A1 Cyclotetrasaccharide for augmenting "active-oxygen-eliminating-activity"
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320589A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320373A2 Treatment of arthritis and compositions therefore
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1320295A1 Collagen/polysaccharide bilayer matrix
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0726074B1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
06/25/2003EP0668879B1 Truncated insulin-like growth factor binding proteins having mitogenic activity
06/25/2003CN1426419A Pharmaceutical compositions containing oligosaccharides and preparation thereof
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426308A Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1425446A Pill for activating collateral flow and removing spur
06/25/2003CN1425431A Bone marrow recovery medicine
06/25/2003CN1425425A Medicine for preventing and curing osteoporosis and its preparing method
06/25/2003CN1425395A Bolus for eliminating arthralgia and activating energy flow in channels and collaterals and its preparing method
06/25/2003CN1425394A Bolus for eliminating arthralgia and activating energy flow in channels and collaterals and its preparing method
06/25/2003CN1112212C Medicine liquid for treating pain of injury
06/25/2003CN1112206C Bone fracture setting medicine powder
06/25/2003CN1112191C Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583162 Chronic dermal ulcers, wound healing
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583143 CRF receptor antagonists and methods relating thereto
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583137 Protease inhibitors
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6583114 Fracture healing using pthrp analogs
06/24/2003US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds
06/24/2003US6582471 Composition and device for in vivo cartilage repair
06/24/2003CA2343439C Compositions useful in the treatment of diseases of connective tissues
06/19/2003WO2003050272A2 Bone development model
06/19/2003WO2003050250A2 Chondrocyte precursors derived from human embryonic stem cells
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050101A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050091A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2003049673A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003WO2003028545A3 Method, instruments, and kit for autologous transplantation
06/19/2003WO2003013436A3 Kavalactone compositions and methods of use
06/19/2003WO2003003999A3 Delivery of a bioactive material
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003US20030114530 A treatment and/or prevention agent for osteoarthritis comprising N-hydroxy-5-ethoxymethyloxy-2(S)-methyl-4(S)-(4-phenoxybenzoyl)amino pentanamide having an inhibitory activity of matrix metalloproteinases
06/19/2003US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114514 Preventing collagen-based leukocyte adhesion and leukocyte adhesion
06/19/2003US20030114482 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114467 Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114432 Antiinflammatory agents; rheumatic diseases; anticancer agents
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030113881 D-enzyme compositions and methods of their use
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113775 7118, a human arginine N-methyltransferase family member and uses therefor
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 820